Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 25, 2025 15:31 ET | Source: Robbins LLP

MLTX Class Action Reminder – Robbins LLP Reminds MoonLake Immunotherapeutics Stockholders of the Opportunity to Lead the Class Action Lawsuit

Robbins LLP alerts investors to a class action involving MoonLake, alleging misleading statements on a drug candidate’s efficacy.
October 27, 2025 17:24 ET | Source: Robbins LLP

MoonLake Stockholders with Large Losses are Encouraged to Contact Robbins LLP for Information About the Class Action Against MLTX

A class action alleges MoonLake misled investors about SLK’s Nanobody advantages over BIMZELX. Phase 3 results showed no superiority, sending shares down 8
October 17, 2025 16:43 ET | Source: Robbins LLP

MLTX Investor Notice: Robbins LLP Reminds Stockholders of the Securities Fraud Class Action Against MoonLake Immunotherapeutics

Robbins LLP is Investigating Allegations that MoonLake Immunotherapeutics (MLTX) Mislead Investors Regarding the Efficacy of its Drug Candidate